These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 891099)

  • 21. Effect of food on bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms: Part I.
    Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):148-52. PubMed ID: 3699941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bioavailability of theophylline after oral administration of a retard preparation of theophylline-ethylenediamine and the influence of 15-day ingestion on elimination kinetics after i.v. injection (author's transl)].
    Wiessmann KJ
    Arzneimittelforschung; 1980; 30(2):329-32. PubMed ID: 7378114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
    van der Vet AP; Drost RH; Kreukniet J; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic studies on proxyphylline administered intravenously and orally to man.
    Graffner C; Johnsson G; Sjögren J
    Acta Pharm Suec; 1973 Dec; 10(6):425-34. PubMed ID: 4773111
    [No Abstract]   [Full Text] [Related]  

  • 25. Theophylline kinetics in acute pulmonary edema.
    Piafsky KM; Sitar DS; Rangno RE; Ogilvie RI
    Clin Pharmacol Ther; 1977 Mar; 21(3):310-6. PubMed ID: 837650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline.
    Fixley M; Shen DD; Azarnoff DL
    Am Rev Respir Dis; 1977 Jun; 115(6):955-62. PubMed ID: 262107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II.
    Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):196-201. PubMed ID: 3710632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW; Zech K; Fischer R
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics in drug therapy II: Applications of clinical pharmacokinetics in the assessment of theophylline therapy.
    Floyd RA; Cohen JL
    Am J Hosp Pharm; 1977 Apr; 34(4):402-7. PubMed ID: 871124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of phenobarbital and chrysene on theophylline elimination determined by noncompartmental analysis.
    Piekoszewski W; Brandys J
    Pol J Pharmacol Pharm; 1987; 39(2):143-6. PubMed ID: 3432160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous theophylline?
    Szymaniak G; Anderer TJ
    Hosp Pharm; 1983 Dec; 18(12):665-6, 670. PubMed ID: 10264360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biopharmaceutical investigation of rectal suppositories. Part 3: Influence of particle size on the bioavailability of drugs.
    Minkov E; Lambov N; Peneva B
    Pharmazie; 1986 Jan; 41(1):63-4. PubMed ID: 3960955
    [No Abstract]   [Full Text] [Related]  

  • 33. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.
    Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Thürkow-Luikens AJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):506-10. PubMed ID: 6500770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of smoking on theophylline disposition.
    Hunt SN; Jusko WJ; Yurchak AM
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):546-51. PubMed ID: 1277710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
    Vu VT; Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliability of theophylline clearance in determining chronic oral dosage regimens.
    Slotfeldt ML; Johnson CE; Grambau G; Weg JG
    Am J Hosp Pharm; 1979 Jan; 36(1):66-8. PubMed ID: 758787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Theophylline pharmacokinetics after intravenous infusion with ethylenediamine or sodium glycinate.
    Caldwell J; Staib AH; Cotgreave IA; Siebert-Weigel M
    Br J Clin Pharmacol; 1986 Sep; 22(3):351-5. PubMed ID: 3768248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].
    Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R
    Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Theophylline disposition following parenteral feeding of malnourished patients.
    Cuddy PG; Bealer JF; Lyman EL; Pemberton LB
    Ann Pharmacother; 1993; 27(7-8):846-51. PubMed ID: 8364261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Disposition of theophylline in healthy non-smoker volunteers after a single oral dose of aminophylline].
    Prat G; Gazitúa R; Arriagada D; Montero J; Serrat H; Ruiz M; Leiva P
    Rev Med Chil; 1986 Dec; 114(12):1164-7. PubMed ID: 3602698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.